产品名称 | NebuSelect™ Recombinant Human FGFR4, hFc-tag |
---|---|
目录号 | NBL-242670 |
别名 | FGFR4; CD334; FGF R4; FGFR4; FGFR-4; MGC20292; JTK2; TKF |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P22455 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242670-100ug | 100ug | Inquire | Inquire | |
NBL-242670-1mg | 1mg | Inquire | Inquire | |
NBL-242670-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human FGFR4, hFc-tag
Catalog#:
NBL-242670
Description:
NebuSelect™ Recombinant Human FGFR4, hFc-tag(Cat#NBL-242670) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu22-Asp369.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 65.3 kDa. Due to glycosylation, the protein migrates to 80-95 kDa based on Bis-Tris PAGE result.
Target Name:
FGFR4; CD334; FGF R4; FGFR4; FGFR-4; MGC20292; JTK2; TKF
Target Information:
Fibroblast growth factor receptor 4 (FGF R4), also known as CD334, is a 110 kDa glycosylated transmembrane receptor tyrosine kinase.Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.